Tuesday, October 31, 2017

Exposants, Visiteurs et Participants Saluent la Diversité de la 19ème édition du WETEX et de la 2ème édition de Dubaï Solar Show

›
Dubaï, Émirats Arabes Unis-Mardi 31 Octobre 2017 [ AETOS Wire ] Le salon de l'eau, de l'énergie, de la technologie et de l'e...

إشادة واسعة من العارضين والزوار والمشاركين بالتنوع الذي شهدته الدورة 19 من معرض "ويتيكس" والثانية من "دبي للطاقة الشمسية"

›
دبي، الإمارات العربية المتحدة -يوم الثُّلَاثاء 31 أكتوبر 2017 [ ايتوس واير ] بات معرض تكنولوجيا المياه والطاقة والبيئة )ويتيكس) موعداً سنو...

Exhibitors, Visitors, and Participants Commend Diversity of 19th WETEX and 2nd Dubai Solar Show

›
Dubai, United Arab Emirates -Tuesday, October 31st 2017 [ AETOS Wire ] The Water, Energy, Technology, and Environment Exhibition (WET...

Efficacy and Safety Results from Second Phase III Trial (RADIANCE™ Part B) of Oral Ozanimod Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting

›
Ozanimod demonstrated superiority versus interferon beta-1a (Avonex®) in reducing annualized relapse rates and MRI brain lesions at tw...

Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM™) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting

›
Incidence of adverse events and serious adverse events similar to Avonex Safety and tolerability profile consistent with prior phase II stu...